Insider · CIK 0001997032
Michal Nath Puri
officer
Files at NVCR (NovoCure Ltd). First filing Nov 4, 2024, latest Mar 5, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $47k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NVCR: NovoCure Ltd
NVCROct 9, 2026 · close 14.58
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | NovoCure Ltd | $15k 1,100 shares | -1% | +34% from low-37% from high | |
| 30Weak | NovoCure Ltd | $20k 1,441 shares | -1% | +36% from low-36% from high | |
| 30Weak | NovoCure Ltd | $13k 810 shares | -1% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 3, 2026 | NVCR NovoCure Ltd | AGrant or award Ordinary Shares | +40,100 | $0.00 | $0 | 202,422 | Mar 5, 2026 |
| Mar 4, 2026 | NVCR NovoCure Ltd | SOpen-market sale Ordinary Shares | -1,100 | $13.31 | $15k | 201,322 | Mar 5, 2026 |
| Mar 3, 2026 | NVCR NovoCure Ltd | AGrant or award Stock Option (Right to Buy)derivative | +58,672 | $0.00 | $0 | 58,672 | Mar 5, 2026 |
| Feb 27, 2026 | NVCR NovoCure Ltd | SOpen-market sale Ordinary Shares | -1,441 | $13.66 | $20k | 162,322 | Mar 3, 2026 |
| Oct 31, 2025 | NVCR NovoCure Ltd | FTax withholding Ordinary Shares | -752 | $12.82 | $9,641 | 163,762 | Nov 4, 2025 |
| Jun 30, 2025 | NVCR NovoCure Ltd | AGrant or award Ordinary Shares | +833 | $15.13 | $13k | 164,514 | Jul 1, 2025 |
| Oct 31, 2024 | NVCR NovoCure Ltd | SOpen-market sale Ordinary Shares | -810 | $15.79 | $13k | 110,093 | Nov 4, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.